BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29658967)

  • 1. Identification of microRNA signature in different pediatric brain tumors.
    Tantawy M; Elzayat MG; Yehia D; Taha H
    Genet Mol Biol; 2018; 41(1):27-34. PubMed ID: 29658967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
    Visani M; de Biase D; Marucci G; Cerasoli S; Nigrisoli E; Bacchi Reggiani ML; Albani F; Baruzzi A; Pession A;
    Mol Oncol; 2014 Mar; 8(2):417-30. PubMed ID: 24412053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of MicroRNA expression in pediatric brain tumors.
    Birks DK; Barton VN; Donson AM; Handler MH; Vibhakar R; Foreman NK
    Pediatr Blood Cancer; 2011 Feb; 56(2):211-6. PubMed ID: 21157891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression in pediatric intracranial ependymomas and their potential value for tumor grading.
    Cipro Š; Belhajová M; Eckschlager T; Zámečník J
    Oncol Lett; 2019 Jan; 17(1):1379-1383. PubMed ID: 30655909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
    Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
    PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
    Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J
    World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of tissue microRNA10b may help predict glioma prognosis.
    Zhang X; Cheng J; Fu L; Li Q
    J Clin Neurosci; 2016 Jul; 29():59-63. PubMed ID: 26988656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression.
    Davidsen PK; Gallagher IJ; Hartman JW; Tarnopolsky MA; Dela F; Helge JW; Timmons JA; Phillips SM
    J Appl Physiol (1985); 2011 Feb; 110(2):309-17. PubMed ID: 21030674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making.
    Browne BM; Stensland KD; Patel CK; Sullivan T; Burks EJ; Canes D; Raman JD; Warrick J; Reiger-Christ KM
    Urology; 2019 Jan; 123():93-100. PubMed ID: 30315887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.
    Sasayama T; Nishihara M; Kondoh T; Hosoda K; Kohmura E
    Int J Cancer; 2009 Sep; 125(6):1407-13. PubMed ID: 19536818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study.
    Aslam MI; Hussein S; West K; Singh B; Jameson JS; Pringle JH
    Int J Surg; 2015 Jan; 13():272-279. PubMed ID: 25496852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
    Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
    J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx].
    Li L; Zhang ZM; Liu Y; Wei MH; Xue LY; Zou SM; Di XB; Han NJ; Zhang KT; Xu ZG; Gao YN
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):391-5. PubMed ID: 21055156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas.
    Son JC; Jeong HO; Park D; No SG; Lee EK; Lee J; Chung HY
    Cancer Inform; 2017; 16():1176935117702878. PubMed ID: 28469392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
    Muñoz-Largacha JA; Gower AC; Sridhar P; Deshpande A; O'Hara CJ; Yamada E; Godfrey TE; Fernando HC; Litle VR
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):714-727. PubMed ID: 28495058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive microRNA Profiling of Prostate Cancer.
    Walter BA; Valera VA; Pinto PA; Merino MJ
    J Cancer; 2013; 4(5):350-7. PubMed ID: 23781281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
    Cheng W; Ren X; Zhang C; Han S; Wu A
    J Neurooncol; 2017 Apr; 132(2):207-218. PubMed ID: 28091987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.
    Ames H; Halushka MK; Rodriguez FJ
    J Neuropathol Exp Neurol; 2017 Apr; 76(4):246-254. PubMed ID: 28431179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.